A CORRELATIVE STUDY OF CALCIFEROL WITH HOMOCYSTEINE, FOLIC ACID, AND COBALAMIN IN THE PATIENTS OF ALZHEIMER’S DISEASE: A CASE-CONTROL STUDY
Main Article Content
Keywords
Alzheimer’s disease, Vitamin D, Vitamin B9, Vitamin B12 and Homocysteine.
Abstract
Background: Alzheimer's disease is a degenerative irreversible brain condition that gradually damages memory, reasoning, and abilities, and ultimately the ability to effectively carry out the most basic tasks. Low level of vitamin D might be the risk factor of Alzheimer's disease. Insufficient levels of folic acid may cause hyperhomocysteinemia, which may lead to oxidative stress in brain tissue and harm neurons.
Aim: The motive of the study was to find out the association and correlation of Vitamin level with folic acid, vitamin B12 and homocysteine in the subjects with Alzheimer’s disease.
Method: This study was included 112 participants, out of these 56 cases and 56 control group. Patients having dementia were included in this study after taken ethical clearance certificate from IEC committee of BHU. Vitamin D, Homocysteine, folic acid and vitamin B12 were estimated for both group (Cases and control).
Result: This study observed negative correlation of vitamin D with Homocysteine and folic acid and positive correlation with vitamin B12, which was found statistically not significant (p-vale >0.05).
Conclusion: Vitamin D and folic acid deficiency is leading cause of Alzheimer’s disease, which can reduced homocysteine level and harm brain tissues.
References
2. Vashistha P, Zahra K, Kumar A, Kumar T, Srivastava M and Mishra SP. Is there a Correlation between Micronutrients and Cognitive Status: An Exploratory Study of Senile Dementia of Alzheimer’s Type. Journal of Clinical and Diagnostic Research. 2018 Apr, Vol-12(4): BC01-BC04. DOI: 10.7860/JCDR/2018/32236.11376.
3. Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, Llewellyn DJ, Raina P. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology. 2012 Sep 25;79(13):1397-405.
4. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. Journal of chemical neuroanatomy. 2005 Jan 1;29(1):21-30.
5. Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH, Fried L, Kestenbaum BR, Kuller LH, Langa KM, Lopez OL, Kos K, Soni M, Llewellyn DJ. Vitamin D and the risk of dementia and Alzheimer disease. Neurology. 2014 Sep 2;83(10):920-8. doi: 10.1212/WNL.0000000000000755. Epub 2014 Aug 6. PMID: 25098535; PMCID: PMC4153851.
6. Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, Zheng X, Espinosa-Jeffrey A, Mahanian M, Liu PT, Hewison M. 1α, 25-Dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-β clearance by macrophages of Alzheimer's disease patients. Journal of Alzheimer’s Disease. 2009 Jul 1;17(3):703-17.
7. Dursun E, Gezen-Ak D, Yilmazer S. A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons. Journal of Alzheimer’s Disease. 2011 Feb 26;23(2):207-19.
8. Annweiler C, Montero‐Odasso M, Hachinski V, Seshadri S, Bartha R, Beauchet O. Vitamin D concentration and lateral cerebral ventricle volume in older adults. Molecular nutrition & food research. 2013 Feb;57(2):267-76.
9. Olaso-Gonzalez G, Inzitari M, Bellelli G, Morandi A, Barcons N, Viña J. Impact of supplementation with vitamins B6 , B12 , and/or folic acid on the reduction of homocysteine levels in patients with mild cognitive impairment: A systematic review. IUBMB Life. 2022 Jan;74(1):74-84. doi: 10.1002/iub.2507. Epub 2021 May 31. PMID: 34058062.
10. Lanyau-Domínguez Y, Macías-Matos C, Llibre-Rodríguez JD, Pita-Rodríguez GM, Suárez-Medina R, Quintero-Alejo ME, Noriega-Fernández L, Guerra-Hernández M, Calvo-Rodríguez M, Sánchez-Gil Y, García-Klibanski M. Levels of vitamins and homocysteine in older adults with Alzheimer disease or mild cognitive impairment in Cuba. MEDICC review. 2021 Jul 7;22:40-7.
11. Smith AD, Refsum H. Homocysteine, B vitamins, and cognitive impairment. Annual review of nutrition. 2016 Jul 17;36(1):211-39.
12. Zaric BL, Obradovic M, Bajic V, Haidara MA, Jovanovic M, Isenovic ER. Homocysteine and hyperhomocysteinaemia. Current medicinal chemistry. 2019 May 1;26(16):2948-61.
13. Baroni L, Bonetto C, Rizzo G, Bertola C, Caberlotto L, Bazzerla G. Association between cognitive impairment and vitamin B12, folate, and homocysteine status in elderly adults: A retrospective study. Journal of Alzheimer’s Disease. 2019 Jul 23;70(2):443-53.
14. Zuliani G, Brombo G, Polastri M, Romagnoli T, Mola G, Riccetti R, Seripa D, Trentini A, Cervellati C. High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia. Neurochemistry international. 2024 Jul 1;177:105763.
15. Liu W, Zheng D, Li X, Wang T, Wang L, Hao L, Ju M, Feng W, Guo Z, Sun X, Yu H. Effects of vitamin D3 combined with folic acid on Domain and specific cognitive function among patients with mild cognitive impairment: a Randomized Clinical Trial. The Journal of Prevention of Alzheimer's Disease. 2024 Dec;11(6):1626-33.
16. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease. Arch Neurol. 1998;55(11):1449–1455. doi:10.1001/archneur.55.11.1449.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Pooja Vashistha
Department of Biochemistry, RMCH, Bareilly. Email ID:poojavashistha8@gmail.com
Apoorva Bansal
Department of Biochemistry, RMCH, Bareilly. Email ID- bansal.apoorva22@gmail.com
Surendra Pratap Mishra
Professor, Department of Biochemistry, IMS, BHU, Varanasi, India
Ashok Singh
Consultant psychiatrist, Gonda, Uttar Pradesh, India